Harm reduction: a public health approach to prison drug use

Int J Prison Health. 2021 Dec 30. doi: 10.1108/IJPH-06-2021-0053. Online ahead of print.

Abstract

Purpose: As prison drug use continues to be a concern worldwide, harm reduction practices serve as an alternative approach to traditional abstinence-only or punishment-oriented methods to address substance use behind bars. The purpose of this study is to present a summary of research surrounding prison-based harm reduction programs.

Design/methodology/approach: This narrative review of the international literature summarizes the harms associated with prison drug use followed by an overview of the literature surrounding three prison-based harm reduction practices: opioid agonist therapy, syringe exchange programs and naloxone distribution.

Findings: A collection of international research has found that these three harm reduction programs are safe and feasible to implement in carceral settings. Additionally, these services can effectively reduce some of the harms associated with prison drug use (e.g. risky injection practices, needle sharing, fatal overdoses, etc.). However, these practices are underused in correctional settings in comparison to their use in the community.

Originality/value: Various policy recommendations are made based on the available literature, including addressing ethical concerns surrounding prison populations' rights to the same standard of health care and services available in the community. By taking a public health approach to prison drug use, harm reduction practices can provide a marginalized, high-risk population of incarcerated individuals with life-saving services rather than punitive, punishment-oriented measures.

Keywords: Correctional health care; Evidence-based substance-use treatment; Harm reduction; Prison drug use; Public health; Substitution treatment.

Publication types

  • Review

MeSH terms

  • Harm Reduction
  • Humans
  • Prisons
  • Public Health
  • Substance Abuse, Intravenous* / epidemiology
  • Substance-Related Disorders*